EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Serial ultrasonographic monitoring during defibrotide treatment of sinusoidal obstruction syndrome after hematopoietic stem cell transplantation: a longitudinal study of treatment response

Jungwoo Lee, Eun Jeong Min, Bohyun Kim, Silvia Park, Yu Ri Shin, Soon Nam Oh, Joon-Il Choi, Sung Eun Rha

Ultrasonography · 2026-11-01 · 45 (6) · 595-606

DOI: 10.14366/usg.26188 ↗
AbstractBibliografische Angaben

Abstract

Purpose: This study evaluated serial ultrasonographic (US) changes during defibrotide therapy for sinusoidal obstruction syndrome (SOS) after hematopoietic stem cell transplantation, identifying parameters whose temporal trajectories differed by treatment response.Methods: This retrospective study included adults treated with defibrotide for SOS between January 2015 and August 2024 with baseline US and at least one follow-up US examination. Response was defined a priori as total bilirubin <2 mg/dL with resolution of SOS-related multiorgan dysfunction. US was repeated weekly until response assessment. HokUS-10 parameters and additional US findings were analyzed using generalized estimating equations and linear mixed-effects models to test the group-by-time interaction. The fully adjusted model was primary, with a minimal model used for sensitivity analysis. P-values were adjusted using the Benjamini-Hochberg procedure.Results: Among 39 patients (23 responders [59.0%] and 16 non-responders [41.0%]; median defibrotide duration, 23 days), only HokUS-10 score showed a significant group-by-time interaction after multiple-testing adjustment in both models, declining more rapidly among responders (fully adjusted model: β=−0.048; 95% confidence interval [CI], −0.083 to −0.013; P=0.017; minimal model: β=−0.053; 95% CI, −0.087 to −0.019; P=0.006). The odds of hepatofugal portal vein flow decreased faster among responders in the fully adjusted model (odds ratio [OR], 0.92; 95% CI, 0.85 to 0.99; P=0.032), whereas the association was directionally similar but non-significant in the minimal model (OR, 0.95; 95% CI, 0.88 to 1.02; P=0.162). Hepatic artery resistive index ≥0.75 was not significantly associated with differential temporal change.Conclusion: Serial US trajectories differed by treatment response. Longitudinal HokUS-10 changes may help distinguish defibrotide responders from non-responders.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →